Your browser doesn't support javascript.
loading
Exploring the genetics of irritable bowel syndrome: a GWA study in the general population and replication in multinational case-control cohorts.
Ek, Weronica E; Reznichenko, Anna; Ripke, Stephan; Niesler, Beate; Zucchelli, Marco; Rivera, Natalia V; Schmidt, Peter T; Pedersen, Nancy L; Magnusson, Patrik; Talley, Nicholas J; Holliday, Elizabeth G; Houghton, Lesley; Gazouli, Maria; Karamanolis, George; Rappold, Gudrun; Burwinkel, Barbara; Surowy, Harald; Rafter, Joseph; Assadi, Ghazaleh; Li, Ling; Papadaki, Evangelia; Gambaccini, Dario; Marchi, Santino; Colucci, Rocchina; Blandizzi, Corrado; Barbaro, Raffaella; Karling, Pontus; Walter, Susanna; Ohlsson, Bodil; Tornblom, Hans; Bresso, Francesca; Andreasson, Anna; Dlugosz, Aldona; Simren, Magnus; Agreus, Lars; Lindberg, Greger; Boeckxstaens, Guy; Bellini, Massimo; Stanghellini, Vincenzo; Barbara, Giovanni; Daly, Mark J; Camilleri, Michael; Wouters, Mira M; D'Amato, Mauro.
Afiliação
  • Ek WE; Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden.
  • Reznichenko A; Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden.
  • Ripke S; Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
  • Niesler B; Department of Human Molecular Genetics, Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany.
  • Zucchelli M; Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden.
  • Rivera NV; Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden.
  • Schmidt PT; Department of Gastroenterology and Hepatology, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden.
  • Pedersen NL; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Magnusson P; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Talley NJ; Faculty of Health and Medicine, University of Newcastle, Newcastle, New South Wales, Australia.
  • Holliday EG; Faculty of Health and Medicine, University of Newcastle, Newcastle, New South Wales, Australia.
  • Houghton L; Faculty of Medical and Human Sciences, Institute of Inflammation and Repair, University of Manchester, Manchester, UK Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida, USA.
  • Gazouli M; Laboratory of Biology, School of Medicine, University of Athens, Athens, Greece.
  • Karamanolis G; Academic Department of Gastroenterology, School of Medicine, University of Athens, Athens, Greece.
  • Rappold G; Department of Human Molecular Genetics, Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany.
  • Burwinkel B; Molecular Epidemiology Group, German Cancer Research Centre (DKFZ) Heidelberg, Heidelberg, Germany Division of Molecular Biology of Breast Cancer, Department of Gynaecology and Obstetrics, University Women's Clinic, University Heidelberg, Heidelberg, Germany.
  • Surowy H; Molecular Epidemiology Group, German Cancer Research Centre (DKFZ) Heidelberg, Heidelberg, Germany Division of Molecular Biology of Breast Cancer, Department of Gynaecology and Obstetrics, University Women's Clinic, University Heidelberg, Heidelberg, Germany.
  • Rafter J; Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden.
  • Assadi G; Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden.
  • Li L; Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden.
  • Papadaki E; Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden.
  • Gambaccini D; Gastroenterology Unit, Department of Gastroenterology, University of Pisa, Pisa, Italy.
  • Marchi S; Gastroenterology Unit, Department of Gastroenterology, University of Pisa, Pisa, Italy.
  • Colucci R; Division of Pharmacology and Chemotherapy, Department of Clinical and Experimental Medicine University of Pisa, Pisa, Italy.
  • Blandizzi C; Division of Pharmacology and Chemotherapy, Department of Clinical and Experimental Medicine University of Pisa, Pisa, Italy.
  • Barbaro R; Department of Medical and Surgical Sciences, University of Bologna, St. Orsola-Malpighi Hospital, Bologna, Italy.
  • Karling P; Department of Medicine, Umeå, University, Umeå, Sweden.
  • Walter S; Division of Gastroenterology, Institution of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
  • Ohlsson B; Department of Clinical Sciences, Skånes University Hospital, Malmoe, Sweden.
  • Tornblom H; Department of Internal Medicine & Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Bresso F; Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden Department of Gastroenterology and Hepatology, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden.
  • Andreasson A; Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden Stress Research Institute, Stockholm University, Stockholm, Sweden.
  • Dlugosz A; Department of Gastroenterology and Hepatology, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden.
  • Simren M; Department of Internal Medicine & Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Agreus L; Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
  • Lindberg G; Department of Gastroenterology and Hepatology, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden.
  • Boeckxstaens G; Translational Research Center for Gastrointestinal Disorders, Leuven University, Leuven, Belgium.
  • Bellini M; Gastroenterology Unit, Department of Gastroenterology, University of Pisa, Pisa, Italy.
  • Stanghellini V; Department of Medical and Surgical Sciences, University of Bologna, St. Orsola-Malpighi Hospital, Bologna, Italy.
  • Barbara G; Department of Medical and Surgical Sciences, University of Bologna, St. Orsola-Malpighi Hospital, Bologna, Italy.
  • Daly MJ; Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
  • Camilleri M; Clinical Enteric Neuroscience Translational and Epidemiological Research, Mayo Clinic, Rochester, Minnesota, USA.
  • Wouters MM; Translational Research Center for Gastrointestinal Disorders, Leuven University, Leuven, Belgium.
  • D'Amato M; Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden.
Gut ; 64(11): 1774-82, 2015 Nov.
Article em En | MEDLINE | ID: mdl-25248455
ABSTRACT

OBJECTIVE:

IBS shows genetic predisposition, but adequately powered gene-hunting efforts have been scarce so far. We sought to identify true IBS genetic risk factors by means of genome-wide association (GWA) and independent replication studies.

DESIGN:

We conducted a GWA study (GWAS) of IBS in a general population sample of 11,326 Swedish twins. IBS cases (N=534) and asymptomatic controls (N=4932) were identified based on questionnaire data. Suggestive association signals were followed-up in 3511 individuals from six case-control cohorts. We sought genotype-gene expression correlations through single nucleotide polymorphism (SNP)-expression quantitative trait loci interactions testing, and performed in silico prediction of gene function. We compared candidate gene expression by real-time qPCR in rectal mucosal biopsies of patients with IBS and controls.

RESULTS:

One locus at 7p22.1, which includes the genes KDELR2 (KDEL endoplasmic reticulum protein retention receptor 2) and GRID2IP (glutamate receptor, ionotropic, delta 2 (Grid2) interacting protein), showed consistent IBS risk effects in the index GWAS and all replication cohorts and reached p=9.31×10(-6) in a meta-analysis of all datasets. Several SNPs in this region are associated with cis effects on KDELR2 expression, and a trend for increased mucosal KDLER2 mRNA expression was observed in IBS cases compared with controls.

CONCLUSIONS:

Our results demonstrate that general population-based studies combined with analyses of patient cohorts provide good opportunities for gene discovery in IBS. The 7p22.1 and other risk signals detected in this study constitute a good starting platform for hypothesis testing in future functional investigations.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome do Intestino Irritável / Estudo de Associação Genômica Ampla Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Gut Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Suécia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome do Intestino Irritável / Estudo de Associação Genômica Ampla Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Gut Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Suécia